Highlights of three metabolites HDL and reduction in blood pressure values after dietary fiber supplementation in overweight and obese normotensive women: a metabolomic study

Metabolomics. 2023 Nov 17;19(12):95. doi: 10.1007/s11306-023-02057-z.

Abstract

Introduction: The prevalence of hypertension and obesity are a worldwide concern.

Objetives: Assess the metabolites profile after intervention with mixed dietary fiber in overweight and obese normotensive women.

Methods: This is a randomized double blind placebo-controlled study. Through a simple randomization process, two groups were allocated, with eleven women (group 1) receiving 12 g of mixed dietary fiber and thirteen women (group 2) receiving 12 g of placebo (corn starch) for eight weeks. Anthropometric and biochemical tests and lifestyle were analyzed. As for evaluation metabolomics, used a 1H NMR. The data matrix generated 96 samples and 225 variables, which was exported in the ASCII format for the "The Unscrumbler" statistics software (version 9.7, CAMO Process).

Results: After the intervention with mixed dietary fiber, significant differences were observed between the main types of metabolites, referring to the increase in the relative peak areas of in three HDL metabolites 4.94 ppm (0.0086*), HDL 1.28 ppm (0 .0337*), HDL 0.88 ppm (0.0224*) and an α-glucose metabolite 4.90 ppm (0.0106) and the reduction in systolic blood pressure (SBP) (0.0292*) of 7 mmHg in the reference range and in the placebo group there was a reduction in SBP (0.0118*) of 4 mmHg and of a choline metabolite 3.65 ppm (0.0266*), which does not call into question the validity of these results in the literature.

Conclusion: The synergism of the functions of these statistically highlighted metabolites contributed to prevention the increase in SBP after fiber intervention in overweight and obese normotensive women.

Keywords: Blood pressure; Dietary fiber; Metabolome; Nuclear magnetic resonance.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Blood Pressure
  • Dietary Supplements
  • Female
  • Humans
  • Metabolomics* / methods
  • Obesity
  • Overweight* / drug therapy